Francois Rochon
Giverny Capital
Giverny Capital Portfolio 13F
Francois Rochon Holdings Activity
- Portfolio value:
- $1.84B≈ (-$58M≈)
- Previous value:
- $1.90B≈
- # of changes:
- 52
- New positions:
- 3
- Reported for:
- 30 Sep 2023 (Q3)
- Latest filing date:
- 25 Jan 2024
Giverny Capital has disclosed a total of 52 changes to the portfolio in the (2023 Q3) SEC report(s): increased the number of shares of 34, bought 3 totally new, decreased the number of shares of 12 and completely sold out 3 position(s).
What stocks did Francois Rochon buy in 2023 Q3?
During 2023 Q3 Francois Rochon has bought 37 securities out of which top 5 purchases (by % change to portfolio) were (BRK-B) Berkshire Hathaway Inc (added shares +1.30%), (AME) Ametek Inc (added shares +0.51%), (MKL) Markel Corp (added shares +0.86%), (KMX) CarMax Inc (added shares +1.35%) and (FIVE) Five Below Inc (added shares +1.71%).
In the 2023 Q3 report(s) the following changes have been made to the top investments: (BRK-B) Berkshire Hathaway Inc (added shares +1.30%), (AME) Ametek Inc (added shares +0.51%), (MKL) Markel Corp (added shares +0.86%), (GOOG) Alphabet Inc, CL-C (reduced shares -0.08%) and (KMX) CarMax Inc (added shares +1.35%).
52 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ferguson Plc
|
new
|
+26,185
|
26,185
|
+0.23%
|
$164.47
|
+40.93%($231.79)
|
0.23%
|
2023 Q3
|
≈ 0.25 years
|
|
|
|
Kinsale Capital Group Inc
|
new
|
+2,555
|
2,555
|
+0.06%
|
$414.13
|
-16.18%($347.10)
|
0.06%
|
2023 Q3
|
≈ 0.25 years
|
|
|
|
Medpace Holdings Inc
|
new
|
+3,760
|
3,760
|
+0.05%
|
$242.13
|
+151.57%($609.13)
|
0.05%
|
2023 Q3
|
≈ 0.25 years
|
|
|
|
Coherent Inc
|
+606.35%
|
+607,517
|
707,710
|
+1.08%
|
$32.64
|
+786.44%($289.34)
|
1.25%
|
2021 Q3
|
≈ 2.25 years
|
|
|
|
Copart Inc
|
+100.00%
|
+13,742
|
27,484
|
+0.03%
|
$43.09
|
-35.30%($27.88)
|
0.06%
|
2022 Q2
|
≈ 1.50 years
|
|
|
|
Novo Nordisk A/S
|
+100.00%
|
+6,200
|
12,400
|
+0.03%
|
$90.94
|
-46.18%($48.94)
|
0.06%
|
2020 Q3
|
≈ 3.25 years
|
|
|
|
Fiserv, Inc
|
+17.74%
|
+48,088
|
319,094
|
+0.29%
|
$112.96
|
-54.65%($51.23)
|
1.96%
|
2023 Q1
|
≈ 0.75 years
|
|
|
|
Bank Ozk
|
+12.07%
|
+25,404
|
235,926
|
+0.05%
|
$37.07
|
+35.58%($50.26)
|
0.47%
|
2018 Q4
|
≈ 5.00 years
|
|
|
|
Mastercard Inc
|
+7.52%
|
+1,452
|
20,760
|
+0.03%
|
$395.91
|
+35.06%($534.74)
|
0.45%
|
2015 Q1
|
≈ 8.75 years
|
|
|
|
JPMorgan Chase & Co
|
+7.36%
|
+2,511
|
36,606
|
+0.02%
|
$145.02
|
+143.15%($352.61)
|
0.29%
|
2016 Q2
|
≈ 7.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.